New Delhi, May 9 (PTI) Shares of Mankind Pharma made a remarkable debut on the stock exchanges on Tuesday, listing with a premium of over 20 per cent against the issue price of Rs 1,080.

The stock began the trade at Rs 1,300, up 20.37 per cent on the BSE. It further zoomed 24.53 per cent to Rs 1,366.

Also Read | RBI Imposes Rs 1.73 Crore Penalty on HSBC for Non-Compliance With Norms.

At the NSE, shares of the company made its debut at Rs 1,300.

The company commanded a market valuation of Rs 54,816.52 crore.

Also Read | Google I/O 2023: Google Search Engine To Become More Appealing, Engaging and Human-Like With AI Integration; Here's All We Know Before the Expected AI Related Official Announcements.

The initial share sale of Mankind Pharma received 15.32 times subscription last month.

The company's IPO was entirely an Offer for Sale (OFS) of 4,00,58,844 equity shares by promoters and other existing shareholders.

Price range for the offer was at Rs 1,026-1,080 a share.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)